[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607103":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":23,"locations":29,"responsibleParty":42,"collaborators":11,"id":46,"slug":11,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":11,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":11,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":11,"overallStatus":32,"whyStopped":11,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Alexandria University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A will receive itraconazole continuous daily regimen","ACTIVE_COMPARATOR",null,[13],"Drug: Itraconazole (ITZ)",{"label":15,"type":10,"description":11,"interventionNames":16},"Group B will receive itraconazole pulse regimen",[13],[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"DRUG","Itraconazole (ITZ)","therapy for tinea capitis orally",[9,15],[24],{"name":25,"role":26,"phone":27,"phoneExt":11,"email":28},"Marina K Aioub","CONTACT","00201223805043","marinaaioub10@gmail.com",[30],{"facility":31,"status":32,"city":33,"state":11,"zip":11,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":11},"Faculty of Medicine","RECRUITING","Alexandria","Egypt","EG",{"type":37,"coordinates":38},"Point",[39,40],29.91582,31.20176,{"lat":40,"lon":39},{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Marina Aioub","general practitioner","100607103",false,"NCT07184203","Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children","Comparative Clinicomycologic and Dermoscopic Study Between Daily and Pulse Therapy of Oral Itraconazole in Tinea Capitis in Children","Inclusion Criteria:\n\n• Tinea capitis patients with ages ranging from 5 to 18 year\n\nExclusion Criteria:\n\n* Patients with contraindications to itraconazole\n* Patients with associated scalp disease.\n* Patients weighing less than 20 Kg.","ALL","5 Years","18 Years",{"count":56,"type":57},120,"ESTIMATED","INTERVENTIONAL",[60],"NA","A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.",[63],"Tinea Capitis","2025-09-14",{"date":66,"type":67},"2025-09-19","ACTUAL",{"date":69,"type":67},"2025-03-09",{"date":71,"type":57},"2025-12-31",{"name":5,"class":6},1]